Former Elanco Animal Health, Johnson & Johnson, Intuitive Surgical, and Enteromedics Business Development Executive Joins Team to Support Growth Opportunities ANN ARBOR, Mich., May 17, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a...
Zomedica Announces First Quarter 2021 Financial Results
ANN ARBOR, Mich, May 12, 2021 -- Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the three months ended March 31,...
Zomedica to Build Direct Sales Force for TRUFORMA® Platform
ANN ARBOR, Mich., April 15, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that it intends to expand its direct sales organization while...
Zomedica Announces First Commercial Sale of Its Truforma® Platform
ANN ARBOR, Mich., March 16, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA® and...
Zomedica Retires Preferred Shares
TRUFORMA® Progressing Toward CommercializationANN ARBOR, Mich., March 08, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it...
Zomedica Corp. Announces Year End 2020 Financial Results
ANN ARBOR, Mich., Feb. 26, 2021 -- Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the year ended December...
Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter
ANN ARBOR, Mich., Feb. 16, 2021 -- Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the underwriter of its previously announced public...
Zomedica Corp. Announces Closing of $173.5 Million Bought Deal
ANN ARBOR, Mich., Feb. 11, 2021 -- Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the closing of its previously announced public...
Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million
ANN ARBOR, Mich., Feb. 08, 2021 -- Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the underwriter has agreed to...
Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares
ANN ARBOR, Mich., Feb. 08, 2021 -- Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has entered into an underwriting agreement with...